Limited access

Upgrade to access all content for this subject

You work at a pharmaceutical company and are responsible for guiding a potential first-in-class drug for lung cancer through clinical trials. Your team has collected preliminary data to validate the pharmokinetics of the drug and has also determined that, at the dosage tested, it is safe in healthy volunteers.

You recently determined that this novel drug, in comparison to a standard treatment for lung cancer, is more effective and potentially safer.

Select an assignment template